Avicenna Centre For Brain Health is the first clinic in the Fraser Valley to provide Esketamine treatment. Esketamine is shown to help and treat patients suffering from Major Depressive Disorder and suicidal thoughts.
What is Esketamine?
Esketamine, also known by the brand name of Spravato, is a new antidepressant approved by Health Canada for treatment resistant major depressive disorder. Esketamine has potential to work quickly and is administered via a nasal spray. It is chemically related to ketamine and many patients start to improve after the first or second treatment, unlike many traditional antidepressants. It is also used to reduce and combat suicidal thoughts and feelings.Esketamine works in between 50 to 70 percent of patients who suffer from treatment-resistant depression. Spravato™ Esketamine (Ketamine) nasal spray is also an appealing alternative for those who are afraid of needles. Spravato™ must be taken with at least one oral antidepressant medication but is faster acting than other traditional antidepressants.
Esketamine care plans vary from patient to patient. Typically, patients will receive two doses a week for the first month with spaced out dosing utilized later to avoid relapse.
It is important to note that most patients experience no side effects during the time between treatments.



